Cooper Cos. (COO): Price and Financial Metrics


Cooper Cos. (COO): $318.51

5.39 (+1.72%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

COO POWR Grades


  • Growth is the dimension where COO ranks best; there it ranks ahead of 68.34% of US stocks.
  • The strongest trend for COO is in Momentum, which has been heading down over the past 179 days.
  • COO ranks lowest in Momentum; there it ranks in the 16th percentile.

COO Stock Summary

  • COO has a higher market value than 87.93% of US stocks; more precisely, its current market capitalization is $20,588,820,296.
  • COO's went public 36.27 years ago, making it older than 92.84% of listed US stocks we're tracking.
  • The volatility of Cooper Companies Inc's share price is greater than that of only 7.28% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to Cooper Companies Inc, a group of peers worth examining would be CSL, IAC, JHX, OTIS, and STE.
  • COO's SEC filings can be seen here. And to visit Cooper Companies Inc's official web site, go to www.coopercos.com.

COO Valuation Summary

  • COO's price/earnings ratio is 9.4; this is 74.25% lower than that of the median Healthcare stock.
  • COO's price/sales ratio has moved up 4.7 over the prior 243 months.
  • Over the past 243 months, COO's EV/EBIT ratio has gone up 36.7.

Below are key valuation metrics over time for COO.

Stock Date P/S P/B P/E EV/EBIT
COO 2021-08-31 8.3 3.6 9.4 52.3
COO 2021-08-30 8.3 3.6 9.4 52.2
COO 2021-08-27 8.3 3.6 9.3 51.9
COO 2021-08-26 8.3 3.6 9.3 51.8
COO 2021-08-25 8.3 3.6 9.3 51.9
COO 2021-08-24 8.3 3.6 9.4 52.0

COO Growth Metrics

    The year over year net cashflow from operations growth rate now stands at 21.61%.
  • The 4 year net cashflow from operations growth rate now stands at 42.34%.
  • The 2 year cash and equivalents growth rate now stands at -51.61%.
COO's revenue has moved up $598,300,000 over the prior 15 months.

The table below shows COO's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 3,029.2 756.9 938.9
2021-09-30 2,922.5 738.6 2,944.7
2021-06-30 2,845 782.4 2,915.6
2021-03-31 2,659.8 671.4 2,355
2020-12-31 2,465.2 504.6 2,249
2020-09-30 2,430.9 486.6 238.4

COO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • COO has a Quality Grade of C, ranking ahead of 72.46% of graded US stocks.
  • COO's asset turnover comes in at 0.332 -- ranking 126th of 186 Medical Equipment stocks.
  • KRMD, XENT, and BIOL are the stocks whose asset turnover ratios are most correlated with COO.

The table below shows COO's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-07-31 0.332 0.660 0.087
2021-04-30 0.339 0.648 0.093
2021-01-31 0.341 0.632 0.077
2020-10-31 0.366 0.631 0.079
2020-07-31 0.374 0.641 0.096
2020-04-30 0.399 0.651 0.122

COO Price Target

For more insight on analysts targets of COO, see our COO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $478.50 Average Broker Recommendation 1.63 (Moderate Buy)

COO Stock Price Chart Interactive Chart >

Price chart for COO

COO Price/Volume Stats

Current price $318.51 52-week high $463.59
Prev. close $313.12 52-week low $297.34
Day low $312.46 Volume 280,200
Day high $320.69 Avg. volume 341,444
50-day MA $338.25 Dividend yield 0.02%
200-day MA $390.21 Market Cap 15.71B

Cooper Cos. (COO) Company Bio


The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company, publicly traded on the NYSE (NYSE:COO). With its headquarters in San Ramon, California, it has a workforce of more than 12,000 employees and consists of two business units, CooperVision (CVI) which manufactures contact lenses, and CooperSurgical (CSI) which manufactures medical devices and fertility and genomic products for the women’s health care market. (Source:Wikipedia)


COO Latest News Stream


Event/Time News Detail
Loading, please wait...

COO Latest Social Stream


Loading social stream, please wait...

View Full COO Social Stream

Latest COO News From Around the Web

Below are the latest news stories about Cooper Companies Inc that investors may wish to consider to help them evaluate COO as an investment opportunity.

The Cooper Companies (COO) Expected to Beat Earnings Estimates: Should You Buy?

The Cooper Companies (COO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | February 24, 2022

CooperCompanies' Vision Business Posts Industry-Leading First-Year Results for Plastic Neutral Contact Lens Program

Equivalent of nearly 28 million plastic bottles diverted from oceans and 171 communities supported

Yahoo | February 23, 2022

The Cooper Companies: Strong Results, Attractive Valuation

The Cooper Companies, Inc. (COO) operates as a medical device company. It operates through the following business units: Cooper Vision and Cooper Surgical. The Cooper Vision business unit brings a refreshing perspective on vision care with a commitment to crafting quality lenses for contact lens wearers. The Cooper Surgical business unit focuses on supplying women's health clinicians with market medical products and treatment options to improve the delivery of healthcare to women. The company was founded in 1958 and is headquartered in San Ramon, California. I am bullish on COO stock.

Stavros Georgiadis on TipRanks | February 18, 2022

CooperCompanies' Approach to Environmental, Social, and Governance (ESG) Topics

We believe that conducting our business in a socially and environmentally responsible manner is important to our long-term success and the future of our planet. It allows us to manage potential ris...

Yahoo | February 18, 2022

CooperCompanies to Present at Oppenheimer’s 32nd Annual Healthcare Conference

SAN RAMON, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will present at Oppenheimer’s 32nd Annual Healthcare Conference on Wednesday, March 16, 2022. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a virtual session scheduled to begin at 3:20 PM ET. A live webcast of the presentation will be available to all interested parties on the Investor Relations section of CooperCompanies’ website at http://investor.coop

Yahoo | February 17, 2022

Read More 'COO' Stories Here

COO Price Returns

1-mo -6.94%
3-mo -24.26%
6-mo -22.40%
1-year -21.87%
3-year -4.23%
5-year 33.94%
YTD -23.97%
2021 15.33%
2020 13.10%
2019 26.27%
2018 16.84%
2017 24.59%

COO Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full COO Dividend History

Continue Researching COO

Want to see what other sources are saying about Cooper Companies Inc's financials and stock price? Try the links below:

Cooper Companies Inc (COO) Stock Price | Nasdaq
Cooper Companies Inc (COO) Stock Quote, History and News - Yahoo Finance
Cooper Companies Inc (COO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5373 seconds.